SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $269,695 | -11.5% | 11,665 | +0.3% | 0.00% | 0.0% |
Q2 2023 | $304,807 | +38.2% | 11,625 | +35.6% | 0.00% | 0.0% |
Q1 2023 | $220,618 | -13.4% | 8,571 | -12.5% | 0.00% | 0.0% |
Q4 2022 | $254,742 | +12.2% | 9,794 | +22.8% | 0.00% | 0.0% |
Q3 2022 | $227,000 | -62.0% | 7,977 | -24.6% | 0.00% | 0.0% |
Q1 2022 | $597,000 | -27.7% | 10,582 | -20.5% | 0.00% | -50.0% |
Q4 2021 | $826,000 | -8.5% | 13,314 | -6.5% | 0.00% | -33.3% |
Q3 2021 | $903,000 | -33.2% | 14,237 | -13.1% | 0.00% | -25.0% |
Q2 2021 | $1,351,000 | +39.1% | 16,390 | +24.2% | 0.00% | +33.3% |
Q1 2021 | $971,000 | +4.2% | 13,198 | +2.7% | 0.00% | 0.0% |
Q4 2020 | $932,000 | – | 12,851 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |